JP2022538170A5 - - Google Patents

Info

Publication number
JP2022538170A5
JP2022538170A5 JP2021577157A JP2021577157A JP2022538170A5 JP 2022538170 A5 JP2022538170 A5 JP 2022538170A5 JP 2021577157 A JP2021577157 A JP 2021577157A JP 2021577157 A JP2021577157 A JP 2021577157A JP 2022538170 A5 JP2022538170 A5 JP 2022538170A5
Authority
JP
Japan
Prior art keywords
treatment
lemborexant
pharmaceutically acceptable
acceptable salt
oral medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021577157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022538170A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/067955 external-priority patent/WO2020263331A1/en
Application filed filed Critical
Priority claimed from PCT/US2020/039674 external-priority patent/WO2020264201A1/en
Publication of JP2022538170A publication Critical patent/JP2022538170A/ja
Publication of JP2022538170A5 publication Critical patent/JP2022538170A5/ja
Priority to JP2025076606A priority Critical patent/JP2025116005A/ja
Pending legal-status Critical Current

Links

JP2021577157A 2019-06-26 2020-06-25 睡眠問題の治療のためのレンボレキサント Pending JP2022538170A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025076606A JP2025116005A (ja) 2019-06-26 2025-05-02 睡眠問題の治療のためのレンボレキサント

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
USPCT/US2019/003933 2019-06-26
US2019003933 2019-06-26
USPCT/US2019/067955 2019-12-20
PCT/US2019/067955 WO2020263331A1 (en) 2019-06-26 2019-12-20 Lemborexant for treating sleep issues
PCT/US2020/039674 WO2020264201A1 (en) 2019-06-26 2020-06-25 Lemborexant for treating sleep issues

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025076606A Division JP2025116005A (ja) 2019-06-26 2025-05-02 睡眠問題の治療のためのレンボレキサント

Publications (2)

Publication Number Publication Date
JP2022538170A JP2022538170A (ja) 2022-08-31
JP2022538170A5 true JP2022538170A5 (https=) 2023-06-21

Family

ID=83059912

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577157A Pending JP2022538170A (ja) 2019-06-26 2020-06-25 睡眠問題の治療のためのレンボレキサント
JP2025076606A Pending JP2025116005A (ja) 2019-06-26 2025-05-02 睡眠問題の治療のためのレンボレキサント

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025076606A Pending JP2025116005A (ja) 2019-06-26 2025-05-02 睡眠問題の治療のためのレンボレキサント

Country Status (1)

Country Link
JP (2) JP2022538170A (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2843952T3 (es) * 2014-10-23 2021-07-21 Eisai R&D Man Co Ltd Composiciones para tratar el insomnio
US11096941B2 (en) * 2016-05-12 2021-08-24 Eisai R&D Management Co.. Ltd. Methods of treating circadian rhythm sleep disorders

Similar Documents

Publication Publication Date Title
TW389696B (en) Accelerated release composition containing bromocriptine
JP2022522270A5 (https=)
JP2505944B2 (ja) （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物
TW200412934A (en) Pharmaceutical formulations of modafinil
JP2021120379A5 (https=)
JP2009543761A (ja) レボドパ／カルビドパの長期間２４時間腸内投与
JP2010535805A5 (https=)
JP2009508854A (ja) 睡眠時呼吸障害の予防及び治療方法及び手段
JP2026035701A5 (https=)
JP2022521233A5 (https=)
JP4996803B2 (ja) 抗高血圧剤に対する抵抗性及び関連状態を処置する方法及び処方物
CN100558358C (zh) 唑尼沙胺在制备用于治疗或预防阻塞性睡眠呼吸暂停的药物中的应用
JP2011520980A5 (https=)
JP2005512946A5 (https=)
JP2004525940A (ja) 火照りの処置のためのデュロキセチン
JP2016505050A5 (https=)
JP2009545546A (ja) リウマチ性疾患の遅延放出型グルココルチコイド治療
WO2016120787A1 (en) Oral n-acetylcysteine in the treatment of upper respiratory tract infections and symptoms
JP2023521492A5 (https=)
WO2017064652A2 (en) Low dose oral dipyridamole compositions and uses thereof
JP2022538170A5 (https=)
JP6514420B2 (ja) 睡眠時無呼吸の処置のためのスルチアム
JP2021530568A5 (https=)
JP4384435B2 (ja) くしゃみ抑制組成物
JP2024523876A5 (https=)